Top Markets
#1 MON MON +2,760.99%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.39%
#4 eCash eCash +37.30%
#5 PinGo PinGo +24.63%
#6 Siren Siren +24.18%
#7 Collector Crypt Collector Crypt +23.96%
#8 SAFEcoin SAFEcoin +19.72%
#9 Janction Janction +19.66%
#10 Velvet Velvet +15.56%
Coin of the day
MON MON
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Classificação em ações #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Preço da ação
$0.30840035
Valor de mercado
$94.37M
Variação (1 dia)
0.00%
Variação (1 ano)
-34.60%
País
FR
Negociar Sensorion SA (ALSEN)

Categoria

Healthcare
Rácio P/B de Sensorion SA (ALSEN)
Rácio P/B em July 2026 TTM: 1.60
De acordo com os relatórios financeiros mais recentes e o preço das ações da Sensorion SA, o rácio P/B atual (TTM) é 1.60. No final de 2023, o rácio P/B era 1.72.
Histórico do rácio P/B da Sensorion SA de 2011 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) 1.60 -36.00%
2024 2.50 45.20%
2023 1.72 27.66%
2022 1.35 -61.30%
2021 3.49 123.40%
2020 1.56 30.96%
2019 1.19 -63.54%
2018 3.27 -14.29%
2017 3.82 0.09%
2016 3.81 33.08%
2015 2.87 -106.25%
2014 -45.83 271.31%
2013 -12.34 -102.18%
2012 567.35 254.28%
2011 160.14 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.8826 330.16%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5189 307.43%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.0637 28.98%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5808 186.30%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.7629 385.18%
NL